Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
The purpose of this study is to establish the therapeutic equivalence of Gengraf® with the standard treatment Neoral® for a treatment period of 6 months in stable renal allograft transplant recipients with respect to drug levels, dosage, and acute graft rejection and other adverse events.
提供机构：
ClinicalTrials.gov
